Profile
Livio Marzo currently works at Thommen Medical AG, as Chief Executive Officer & Director from 2009 and Mathys AG Bettlach, as Chairman-Supervisory Board from 2008.
Livio Marzo active positions
Companies | Position | Start |
---|---|---|
Thommen Medical AG
Thommen Medical AG Medical SpecialtiesHealth Technology Thommen Medical AG develops and manufactures dental implant systems. It offers include implants, prosthetics, digital solutions, and case planning. The company Grenchen, Switzerland. | Chief Executive Officer | - |
Mathys AG Bettlach
Mathys AG Bettlach Medical SpecialtiesHealth Technology Part of Enovis Corp., Mathys AG Bettlach is a company that focuses on developing innovative solutions in collaboration with clinical partners to enable mobility preservation. Mathys AG Bettlach is based in Bettlach, Switzerland. Mathys AG Bettlach was acquired by DJO LLC from Mathys AG on July 28, 2021 for $299.28 million. The Swiss company values international exchange with surgeons to address previously unresolved clinical problems. The company was founded in 1946 by Robert Mathys, and Benjamin Reinmann has been the CEO of the company since 2017. | Chairman | 01/01/2008 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Thommen Medical AG
Thommen Medical AG Medical SpecialtiesHealth Technology Thommen Medical AG develops and manufactures dental implant systems. It offers include implants, prosthetics, digital solutions, and case planning. The company Grenchen, Switzerland. | Health Technology |
Mathys AG Bettlach
Mathys AG Bettlach Medical SpecialtiesHealth Technology Part of Enovis Corp., Mathys AG Bettlach is a company that focuses on developing innovative solutions in collaboration with clinical partners to enable mobility preservation. Mathys AG Bettlach is based in Bettlach, Switzerland. Mathys AG Bettlach was acquired by DJO LLC from Mathys AG on July 28, 2021 for $299.28 million. The Swiss company values international exchange with surgeons to address previously unresolved clinical problems. The company was founded in 1946 by Robert Mathys, and Benjamin Reinmann has been the CEO of the company since 2017. | Health Technology |
- Stock Market
- Insiders
- Livio Marzo